Related references
Note: Only part of the references are listed.UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation (vol 494, pg 121, 2020)
Hang Yin et al.
CANCER LETTERS (2022)
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
Jianxiong Ji et al.
CELL DEATH AND DIFFERENTIATION (2021)
UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance
Yumei Huang et al.
CELL DEATH AND DIFFERENTIATION (2021)
A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
Zeyuan Yu et al.
ONCOGENE (2021)
TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains
Ai Kaiho-Soma et al.
MOLECULAR CELL (2021)
The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression
Nicole Pui Yu Ho et al.
CELL DEATH & DISEASE (2021)
Pathogenetic Features and Current Management of Glioblastoma
Hong-My Nguyen et al.
CANCERS (2021)
Ubiquitination and Deubiquitination in Oral Disease
Sachio Tsuchida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Hong-My Nguyen et al.
ONCOLYTIC VIROTHERAPY (2021)
UBE2C Is Upregulated by Estrogen and Promotes Epithelial-Mesenchymal Transition via p53 in Endometrial Cancer
Yan Liu et al.
MOLECULAR CANCER RESEARCH (2020)
UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop
Xu Liu et al.
CELL DEATH & DISEASE (2020)
Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling
Xia Wu et al.
CANCER LETTERS (2020)
UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT
Peng Huang et al.
AGING-US (2020)
Effect of 1α,25(OH)2 Vitamin D3 in Mutant P53 Glioblastoma Cells: Involvement of Neutral Sphingomyelinase1
Samuela Cataldi et al.
CANCERS (2020)
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
Yuan Gao et al.
CANCER SCIENCE (2019)
Circular RNA hsa_circ_0006848 Related to Ribosomal Protein L6 Acts as a Novel Biomarker for Early Gastric Cancer
Jun Lu et al.
DISEASE MARKERS (2019)
DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line
Yuki Toda et al.
ANTICANCER RESEARCH (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination
Bingyu Liu et al.
NATURE IMMUNOLOGY (2017)
TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination
Jindong Zhang et al.
CELL DEATH & DISEASE (2017)
Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist
V. Ubertini et al.
ONCOGENE (2015)
Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
Xiang Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
SOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axis
Jing Zhang et al.
BMC NEUROLOGY (2014)
Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress
Dongmei Bai et al.
NUCLEIC ACIDS RESEARCH (2014)
A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
Alessia Garufi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Aurora kinase B/C inhibition impairs malignant glioma growth in vivo
Roberto Jose Diaz et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Regulation of gene expression by the ubiquitin-proteasome system
Tingting Yao et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Downregulation of RPL6 by siRNA Inhibits Proliferation and Cell Cycle Progression of Human Gastric Cancer Cell Lines
Qiong Wu et al.
PLOS ONE (2011)
Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells
Yawen Gou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Ubiquitin becomes ubiquitous in cancer Emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets
Dingding Shi et al.
CANCER BIOLOGY & THERAPY (2010)
Misconceptions about Breast Lumps and Delayed Medical Presentation in Urban Breast Cancer Patients
Garth H. Rauscher et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells
Tomomi Ueki et al.
CANCER RESEARCH (2009)
Targeting the ubiquitin-proteasome system for cancer therapy
Yili Yang et al.
CANCER SCIENCE (2009)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase
T Bartke et al.
MOLECULAR CELL (2004)
Share Paper
